Hillsdale Investment Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Hillsdale Investment Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,184,300	Closed	-$3.67M	–	645
2021 Q4	$3.67M	Hold	1,184,300	–	–	0.25%	135
2021 Q3	$4.28M	Buy	1,184,300 +307,300	+35%	+$1.16M	0.33%	103
2021 Q2	$3.14M	Hold	877,000	–	–	0.25%	136
2021 Q1	$3.43M	Buy	+877,000	New	+$3.62M	0.29%	123
2020 Q1	–	Sell	-136,600	Closed	-$863K	–	709
2019 Q4	$863K	Buy	+136,600	New	+$803K	0.08%	228
2019 Q3	–	Sell	-165,100	Closed	-$768K	–	709
2019 Q2	$768K	Buy	+165,100	New	+$769K	0.08%	250

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.76B AUM 40.74% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Hillsdale Investment Management's BDSI Position: Q1 2022 in Review

Hillsdale Investment Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 1,184,300 shares — an estimated $3.67M sold.

Hillsdale Investment Management first reported a position in BDSI in Q2 2019 and held it in 6 quarters. The position peaked at $4.28M in Q3 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

Hillsdale Investment Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
Hillsdale Investment Management sold 1,184,300 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $3.67M.
Hillsdale Investment Management first reported a position in BioDelivery Sciences International, Inc. in Q2 2019 and held it in 6 quarters.
Hillsdale Investment Management's BioDelivery Sciences International, Inc. position peaked at $4.28M in Q3 2021.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Hillsdale Investment Management's 13F filing for Q1 2022, filed 28 Apr 2022.